Literature DB >> 17619169

'In a completely different light'? The role of 'being affected' for the epistemic perspectives and moral attitudes of patients, relatives and lay people.

Silke Schicktanz1, Mark Schweda, Martina Franzen.   

Abstract

In this paper, we explore and discuss the use of the concept of being affected in biomedical decision making processes in Germany. The corresponding German term 'Betroffenheit' characterizes on the one hand a relation between a state of affairs and a person and on the other an emotional reaction that involves feelings like concern and empathy with the suffering of others. An example for the increasing relevance of being affected is the postulation of the participation of people with disabilities and chronic or acute diseases in the discourse, as partly realized in the German National Ethics Council or the Federal Joint Committee. Nevertheless, not only on the political level, the resistance against the participation of affected people is still strong; the academic debate seems to be cross-grained, too. Against this background, we explore the meaning and argumentative role of the concept of being affected as it is used by affected and lay people themselves. Our analysis is based on four focus group discussions in which lay people, patients and relatives of patients discuss their attitudes towards biomedical interventions such as organ transplantation and genetic testing. This setting allows for a comparison of how affected and non-affected people are concerned and deliberate about medical opportunities, but also of how they position themselves as being affected or non-affected with respect to (scientific) knowledge and morality. On this basis, we discuss the normative relevance of being affected for the justification of political participation.

Entities:  

Mesh:

Year:  2007        PMID: 17619169     DOI: 10.1007/s11019-007-9074-2

Source DB:  PubMed          Journal:  Med Health Care Philos        ISSN: 1386-7423


  5 in total

Review 1.  Genetics and culture: the geneticization thesis.

Authors:  H A ten Have
Journal:  Med Health Care Philos       Date:  2001

2.  Impure science: AIDS, activism, and the politics of knowledge.

Authors:  S Epstein
Journal:  Med Soc (Berkeley)       Date:  1996

3.  The birth of the empirical turn in bioethics.

Authors:  Pascal Borry; Paul Schotsmans; Kris Dierickx
Journal:  Bioethics       Date:  2005-02       Impact factor: 1.898

4.  Social benefit versus technological risk.

Authors:  C Starr
Journal:  Science       Date:  1969-09-19       Impact factor: 47.728

Review 5.  The expert patient: valid recognition or false hope?

Authors:  David Badcott
Journal:  Med Health Care Philos       Date:  2005
  5 in total
  13 in total

1.  The French bioethics public consultation and the anonymity doctrine: empirical ethics and normative assumptions.

Authors:  Marta Spranzi; Laurence Brunet
Journal:  Monash Bioeth Rev       Date:  2015-03

2.  Mitochondrial Replacement Techniques : Examining Collective Representation in Emerging Technologies Governance.

Authors:  Jacquelyne Luce
Journal:  J Bioeth Inq       Date:  2018-07-31       Impact factor: 1.352

3.  Understanding collective agency in bioethics.

Authors:  Katharina Beier; Isabella Jordan; Claudia Wiesemann; Silke Schicktanz
Journal:  Med Health Care Philos       Date:  2016-09

4.  "What the patient wants…": Lay attitudes towards end-of-life decisions in Germany and Israel.

Authors:  Julia Inthorn; Silke Schicktanz; Nitzan Rimon-Zarfaty; Aviad Raz
Journal:  Med Health Care Philos       Date:  2015-08

5.  Interpreting advance directives: ethical considerations of the interplay between personal and cultural identity.

Authors:  Silke Schicktanz
Journal:  Health Care Anal       Date:  2009-05-08

6.  The ethics of 'public understanding of ethics'--why and how bioethics expertise should include public and patients' voices.

Authors:  Silke Schicktanz; Mark Schweda; Brian Wynne
Journal:  Med Health Care Philos       Date:  2012-05

7.  Beyond cultural stereotyping: views on end-of-life decision making among religious and secular persons in the USA, Germany, and Israel.

Authors:  Mark Schweda; Silke Schicktanz; Aviad Raz; Anita Silvers
Journal:  BMC Med Ethics       Date:  2017-02-17       Impact factor: 2.652

8.  Illness and disease: an empirical-ethical viewpoint.

Authors:  Anna-Henrikje Seidlein; Sabine Salloch
Journal:  BMC Med Ethics       Date:  2019-01-09       Impact factor: 2.652

9.  Why the way we consider the body matters - reflections on four bioethical perspectives on the human body.

Authors:  Silke Schicktanz
Journal:  Philos Ethics Humanit Med       Date:  2007-12-04       Impact factor: 2.464

10.  Involving Patient Groups in Drug Research: A Systematic Review of Reasons.

Authors:  Christoph Rach; Jan Lukas; Regina Müller; Matthias Sendler; Peter Simon; Sabine Salloch
Journal:  Patient Prefer Adherence       Date:  2020-03-12       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.